SCHEMBL127142

SCHEMBL127142

CCOC(=O)CCCC(C)C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.57
KMT2A Q03164 2/20 0.47
POLB P06746 1/20 0.47
GAA P10253 2/20 0.46
MGAM O43451 1/20 0.46
SI P14410 1/20 0.46
MGAM2 Q2M2H8 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
NR1I2 O75469 1/20 0.46
PGR P06401 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
PTGS2 P35354 1/20 0.46
PDE4D Q08499 1/20 0.46
MAPT P10636 1/20 0.44
ALDH1A1 P00352 2/20 0.43
CYP3A4 P08684 2/20 0.43
TSHR P16473 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL952321 0.94 CYP1A2 (0.55) CYP1A2KMT2APOLBGAAMGAM
SCHEMBL29183643 0.92 CYP1A2 (0.53) CYP1A2KMT2APOLBGAAMGAM
SCHEMBL4087075 0.92 CYP1A2 (0.53) CYP1A2KMT2APOLBGAAMAPT
SCHEMBL17000166 0.92 CYP1A2 (0.53) CYP1A2KMT2APOLBGAAMAPT
SCHEMBL17000165 0.92 CYP1A2 (0.53) CYP1A2KMT2APOLBGAAMAPT
SCHEMBL29183571 0.92 CYP1A2 (0.53) CYP1A2KMT2APOLBGAAMGAM
SCHEMBL19861152 0.92 CYP1A2 (0.53) CYP1A2KMT2APOLBGAAMAPT
SCHEMBL15130566 0.92 CYP1A2 (0.53) CYP1A2KMT2APOLBGAAMAPT
SCHEMBL29074095 0.92 CYP1A2 (0.53) CYP1A2KMT2APOLBGAAMAPT
SCHEMBL2209491 0.92 CYP1A2 (0.53) CYP1A2KMT2APOLBGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1135363-B1 PROCESS FOR THE PREPARATION OF SYMMETRICAL DIACYLHYDRAZINES GREAT LAKES CHEMICAL EUROP (CH) 2003-09-24 EP claimed
US-6444848-B1 REACTING HYDRAZINE WITH ACID CHLORIDE GREAT LAKES CHEMICAL (EUROPE) GMBH (DE) 2002-09-03 US claimed
WO-2024037293-A1 CELLULAR MATRIX NERVE GRAFT FOR REPAIRING PERIPHERAL NERVE INJURY AND PREPARATION METHOD THEREFOR 南通大学 2024-02-22 WO disclosed
CN-113880691-B Method for synthesizing trimethyl dodecanol 四川众邦新材料股份有限公司 2023-09-01 CN disclosed
CN-116410874-A Pichia pastoris fermentation strain and application thereof in preparation of fermented sour meat 湖南农业大学 2023-07-11 CN disclosed
CN-110803993-B Synthetic method of pregabalin intermediate ethyl 2-carboxyethyl-3-nitromethylene-5-methylhexanoate 陕西科技大学 2023-06-30 CN disclosed
CN-109952360-B Quantum dot dispersion, self-luminous photosensitive resin composition, color filter manufactured using the same, and image display device 东友精细化工有限公司 2022-03-22 CN disclosed
CN-113880691-A Method for synthesizing trimethyl dodecynol 四川众邦制药有限公司 2022-01-04 CN disclosed
CN-108250369-A A kind of preparation method of low smell high-weatherability polymer polyatomic alcohol 万华化学集团股份有限公司 2018-07-06 CN disclosed
CN-107567443-A biaryl derivatives as GPR120 agonists 株式会社LG化学 2018-01-09 CN disclosed
US-20170320865-A1 OXAZOLE OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2017-11-09 US disclosed
US-6384065-B1 CONTROL THE FUNCTIONS OF PROTEINS SUCH AS ENZYMES AND RECEPTOR FORTREATING INFLAMMATORY DISEASES SUCH AS RHEUMATOID ARTHRITIS, TOYAMA CHEMICAL CO., LTD. (JP) 2002-05-07 US disclosed
US-20010034966-A1 Method of reducing the vapor pressure of ethanol-containing motor fuels for spark ignition combustion engines GOLUBKOV ANGELICA (SE) 2001-11-01 US disclosed
EP-1135363-A1 PROCESS FOR THE PREPARATION OF SYMMETRICAL DIACYLHYDRAZINES Great Lakes Chemical (Europe) GmbH (CH) 2001-09-26 EP disclosed
EP-1076056-A1 NOVEL SPIRO COMPOUNDS OR SALTS THEREOF AND PREVENTIVES/REMEDIES FOR AUTOIMMUNE DISEASES AND AP-1 INHIBITORS CONTAINING THE SAME TOYAMA CHEMICAL CO., LTD. (JP) 2001-02-14 EP disclosed
WO-2000034227-A1 PROCESS FOR THE PREPARATION OF SYMMETRICAL DIACYLHYDRAZINES GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) 2000-06-15 WO disclosed
EP-0000352-B1 CYCLIC AROMATIC DIESTERS OF PHOSPHONOUS ACID AND THE ORGANIC MATERIALS STABILIZED BY THEM CIBA-GEIGY AG (CH) 1982-05-05 EP disclosed
US-4276232-A FOR PLASTICS AND ELASTOMERS CIBA-GEIGY CORPORATION (US) 1981-06-30 US disclosed
EP-0000352-A1 Cyclic aromatic diesters of phosphonous acid and the organic materials stabilized by them CIBA-GEIGY AG (CH) 1979-01-24 EP disclosed
EP-0000354-A1 Mixtures that contain phosphonite, and polymers stabilized therewith CIBA-GEIGY AG (CH) 1979-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170320865-A1 OXAZOLE OREXIN RECEPTOR ANTAGONISTS HCRTR2, HCRTR1, OXTR CYP1A2 1423/4885KMT2A 1715/4885POLB 4726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.